Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation

Pál Pacher, Jon G. Mabley, Francisco G. Soriano, Lucas Liaudet, Katalin Komjáti, Csaba Szabo

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Recent work has demonstrated the production of reactive oxygen and nitrogen species in the vasculature of aging animals. Oxidant induced cell injury triggers the activation of nuclear enzyme poly(ADP ribose) polymerase (PARP) leading to endothelial dysfunction in various pathophysiological conditions (reperfusion, shock, diabetes). Here we studied whether the loss of endothelial function in aging rats is dependent upon the PARP pathway within the vasculature. Young (3 months-old) and aging (22 months-old) Wistar rats were treated for 2 months with vehicle or the PARP inhibitor PJ34. In the vehicle-treated aging animals there was a significant loss of endothelial function, as measured by the relaxant responsiveness of vascular rings to acetylcholine. Treatment with PJ34, a potent PARP inhibitor, restored normal endothelial function. There was no impairment of the contractile function and endothelium-independent vasodilatation in aging rats. Furthermore, we found no deterioration in the myocardial contractile function in aging animals. Thus, intraendothelial PARP activation may contribute to endothelial dysfunction associated with aging.

Original languageEnglish (US)
Pages (from-to)1347-1350
Number of pages4
JournalBritish Journal of Pharmacology
Volume135
Issue number6
StatePublished - 2002
Externally publishedYes

Fingerprint

Poly(ADP-ribose) Polymerases
Reactive Nitrogen Species
Enzyme Activation
Oxidants
Vasodilation
Acetylcholine
Reperfusion
Endothelium
Blood Vessels
Wistar Rats
Shock
Reactive Oxygen Species
Wounds and Injuries
Poly(ADP-ribose) Polymerase Inhibitors
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride

Keywords

  • Aging
  • Cardiac function
  • Endothelial dysfunction
  • Poly(ADP ribose) polymerase

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pacher, P., Mabley, J. G., Soriano, F. G., Liaudet, L., Komjáti, K., & Szabo, C. (2002). Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation. British Journal of Pharmacology, 135(6), 1347-1350.

Endothelial dysfunction in aging animals : The role of poly(ADP-ribose) polymerase activation. / Pacher, Pál; Mabley, Jon G.; Soriano, Francisco G.; Liaudet, Lucas; Komjáti, Katalin; Szabo, Csaba.

In: British Journal of Pharmacology, Vol. 135, No. 6, 2002, p. 1347-1350.

Research output: Contribution to journalArticle

Pacher, P, Mabley, JG, Soriano, FG, Liaudet, L, Komjáti, K & Szabo, C 2002, 'Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation', British Journal of Pharmacology, vol. 135, no. 6, pp. 1347-1350.
Pacher, Pál ; Mabley, Jon G. ; Soriano, Francisco G. ; Liaudet, Lucas ; Komjáti, Katalin ; Szabo, Csaba. / Endothelial dysfunction in aging animals : The role of poly(ADP-ribose) polymerase activation. In: British Journal of Pharmacology. 2002 ; Vol. 135, No. 6. pp. 1347-1350.
@article{0ad26896bebe46db8325d20f73d79a76,
title = "Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation",
abstract = "Recent work has demonstrated the production of reactive oxygen and nitrogen species in the vasculature of aging animals. Oxidant induced cell injury triggers the activation of nuclear enzyme poly(ADP ribose) polymerase (PARP) leading to endothelial dysfunction in various pathophysiological conditions (reperfusion, shock, diabetes). Here we studied whether the loss of endothelial function in aging rats is dependent upon the PARP pathway within the vasculature. Young (3 months-old) and aging (22 months-old) Wistar rats were treated for 2 months with vehicle or the PARP inhibitor PJ34. In the vehicle-treated aging animals there was a significant loss of endothelial function, as measured by the relaxant responsiveness of vascular rings to acetylcholine. Treatment with PJ34, a potent PARP inhibitor, restored normal endothelial function. There was no impairment of the contractile function and endothelium-independent vasodilatation in aging rats. Furthermore, we found no deterioration in the myocardial contractile function in aging animals. Thus, intraendothelial PARP activation may contribute to endothelial dysfunction associated with aging.",
keywords = "Aging, Cardiac function, Endothelial dysfunction, Poly(ADP ribose) polymerase",
author = "P{\'a}l Pacher and Mabley, {Jon G.} and Soriano, {Francisco G.} and Lucas Liaudet and Katalin Komj{\'a}ti and Csaba Szabo",
year = "2002",
language = "English (US)",
volume = "135",
pages = "1347--1350",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Endothelial dysfunction in aging animals

T2 - The role of poly(ADP-ribose) polymerase activation

AU - Pacher, Pál

AU - Mabley, Jon G.

AU - Soriano, Francisco G.

AU - Liaudet, Lucas

AU - Komjáti, Katalin

AU - Szabo, Csaba

PY - 2002

Y1 - 2002

N2 - Recent work has demonstrated the production of reactive oxygen and nitrogen species in the vasculature of aging animals. Oxidant induced cell injury triggers the activation of nuclear enzyme poly(ADP ribose) polymerase (PARP) leading to endothelial dysfunction in various pathophysiological conditions (reperfusion, shock, diabetes). Here we studied whether the loss of endothelial function in aging rats is dependent upon the PARP pathway within the vasculature. Young (3 months-old) and aging (22 months-old) Wistar rats were treated for 2 months with vehicle or the PARP inhibitor PJ34. In the vehicle-treated aging animals there was a significant loss of endothelial function, as measured by the relaxant responsiveness of vascular rings to acetylcholine. Treatment with PJ34, a potent PARP inhibitor, restored normal endothelial function. There was no impairment of the contractile function and endothelium-independent vasodilatation in aging rats. Furthermore, we found no deterioration in the myocardial contractile function in aging animals. Thus, intraendothelial PARP activation may contribute to endothelial dysfunction associated with aging.

AB - Recent work has demonstrated the production of reactive oxygen and nitrogen species in the vasculature of aging animals. Oxidant induced cell injury triggers the activation of nuclear enzyme poly(ADP ribose) polymerase (PARP) leading to endothelial dysfunction in various pathophysiological conditions (reperfusion, shock, diabetes). Here we studied whether the loss of endothelial function in aging rats is dependent upon the PARP pathway within the vasculature. Young (3 months-old) and aging (22 months-old) Wistar rats were treated for 2 months with vehicle or the PARP inhibitor PJ34. In the vehicle-treated aging animals there was a significant loss of endothelial function, as measured by the relaxant responsiveness of vascular rings to acetylcholine. Treatment with PJ34, a potent PARP inhibitor, restored normal endothelial function. There was no impairment of the contractile function and endothelium-independent vasodilatation in aging rats. Furthermore, we found no deterioration in the myocardial contractile function in aging animals. Thus, intraendothelial PARP activation may contribute to endothelial dysfunction associated with aging.

KW - Aging

KW - Cardiac function

KW - Endothelial dysfunction

KW - Poly(ADP ribose) polymerase

UR - http://www.scopus.com/inward/record.url?scp=0036215470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036215470&partnerID=8YFLogxK

M3 - Article

C2 - 11906946

AN - SCOPUS:0036215470

VL - 135

SP - 1347

EP - 1350

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 6

ER -